The latest price target for Johnson & Johnson (NYSE:JNJ) was reported by Leerink Partners on May 13, 2026. The analyst firm set a price target for $265.00 expecting JNJ to rise to within 12 months (a possible 13.25% upside). 55 analyst firms have reported ratings in the last year.

The latest analyst rating for Johnson & Johnson (NYSE:JNJ) was provided by Leerink Partners, and Johnson & Johnson upgraded their outperform rating.

The last upgrade for Johnson & Johnson happened on May 13, 2026 when Leerink Partners raised their price target to $265. Leerink Partners previously had a market perform for Johnson & Johnson.

The last downgrade for Johnson & Johnson happened on October 22, 2025 when Freedom Broker changed their price target from $180 to $190 for Johnson & Johnson.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Johnson & Johnson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Johnson & Johnson was filed on May 13, 2026 so you should expect the next rating to be made available sometime around May 13, 2027.

While ratings are subjective and will change, the latest Johnson & Johnson (JNJ) rating was a upgraded with a price target of $0.00 to $265.00. The current price Johnson & Johnson (JNJ) is trading at is $234.00, which is within the analyst’s predicted range.